Efficacy of Jobelyn™ Consumption on Hemoglobin Levels in a Borderline Anemic Population
Completed · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Anemia
In brief
The purpose of this study is to evaluate the timing and magnitude of improvements to red blood cell health associated with consumption of Jobelyn™.
Key facts
- Study ID
- NCT01828060
- Run by
- Natural Immune Systems Inc
- People needed
- 25
- Starts
- 2013-04-01
- Last updated by the study team
- 2014-09-25
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 18-65 year old people of either gender
- Borderline anemic (This is compensated for altitude of study location):
- Hemoglobin level at or below 13.5 g/dL(women)
- Hemoglobin level at or below 15.5 g/dL(men)
You may not qualify if…
- Known diagnosis with pernicious or other megaloblastic anemias, aplastic, sickle cell, thalassemia, autoimmune hemolytic anemias;
- Known diagnosis with Hashimoto's Disease;
- Known chronic kidney disease;
- Rheumatoid arthritis;
- Splenectomy;
- Serious active illness within past 12 months;
- Active cancer and/or chemotherapy within the last 12 months;
- Major surgery during past 8 weeks;
- Scheduled surgery during study;
- Received blood transfusion during the past 8 weeks;
- Having donated blood for 6 weeks prior to study, or planning to donate blood during the 8 week study;
- Distance athlete;
- Unable to commit to staying on a constant regimen of medication and supplements for the duration of the study, with the exception of changes to medication needed for optimal care;
- Changes to prescription medication within 2 weeks before starting the study;
- Participation in other clinical trials during the month before this study begins;
- Participating in other clinical trials during this study;
- Current use of any dietary supplements that may affect hemoglobin levels; Vitamin B12 (over 500 mcg), Iron (over 100mg), or any other dietary supplement that, in the opinion of the investigator, may affect hemoglobin levels;
- Currently experiencing intense stressful events/ life changes that would negatively affect compliance;
- Previous major gastrointestinal surgery (absorption of test product may be altered) (minor surgery is not a problem, including appendix and gallbladder removal);
- Females of child-bearing potential: Pregnant, nursing, or trying to become pregnant;
- Food allergies related to sorghum or rice.
Where it is running
- NIS Labs — Klamath Falls, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.